1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study.
Webb JG, Hensey M, Szerlip M, Schäfer U, Cohen GN, Kar S, Makkar R, Kipperman RM, Spargias K, O'Neill WW, Ng MKC, Fam NP, Rinaldi MJ, Smith RL, Walters DL, Raffel CO, Levisay J, Latib A, Montorfano M, Marcoff L, Shrivastava M, Boone R, Gilmore S, Feldman TE, Lim DS.
Webb JG, et al.
JACC Cardiovasc Interv. 2020 Oct 26;13(20):2344-2357. doi: 10.1016/j.jcin.2020.06.019.
JACC Cardiovasc Interv. 2020.
PMID: 33092709
Free article.
At 30 days, there was 1 cardiovascular death (0.9%), MR 1+ was achieved in 80% of patients (77% FMR, 86% DMR) and MR 2+ in 96% (96% FMR, 97% DMR), 88% of patients were in New York Heart Association functional class I or II, 6-min walk distance had improved by 28 m, and Kan …
At 30 days, there was 1 cardiovascular death (0.9%), MR 1+ was achieved in 80% of patients (77% FMR, 86% DMR) and MR 2+ in 96% (96% FMR, 97% …